Recombinant human ANGPTL2 promotes atherosclerosis in mice [22], while a single delivery of a shRNA targeting angptl2 in young atherosclerotic mice slows aortic lesion growth by inducing apoptosis of senescent EC [23]. Here, ANGPTL2 is linked to atherosclerosis.